LncRNA CDKN2B-AS1 contributes to tumorigenesis and chemoresistance in pediatric T-cell acute lymphoblastic leukemia through miR-335-3p/TRAF5 axis.

Chen, Longfeng; Shi, Yanxiang; Li, Jing; Yang, Xinli; Li, Ruiyan; Zhou, Xiaohong; Zhu, Lanjie

Chen, Longfeng; Shi, Yanxiang; Li, Jing; Yang, Xinli; Li, Ruiyan; Zhou, Xiaohong; Zhu, Lanjie.

Afiliação

Chen L; Department of Pediatrics, Juxian People's Hospital, Rizhao.
Shi Y; Department of Pediatrics, Juxian People's Hospital, Rizhao.
Li J; Department of Pediatrics, Tai An TSCM Hospital.
Yang X; Department of Pediatrics, Taian City Central Hospital, Taian, Shandong, China.
Li R; Department of Pediatrics, Juxian People's Hospital, Rizhao.
Zhou X; Department of Pediatrics, Juxian People's Hospital, Rizhao.
Zhu L; Department of Pediatrics, Juxian People's Hospital, Rizhao.

Anticancer Drugs ; 2020 Sep 25.

Article em En | MEDLINE | ID: mdl-32976214

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Anticancer Drugs Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2020 Tipo de documento: Article País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google